Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: Validation of a new booster dose strategy

Vaccine

Volumn 18, Issue 24, 2000, Pages 2661-2667

  Strady, C ^a   Jaussaud, R ^a   Beguinot I ^a   Lienard, M ^b   Strady, A ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

^b Caisse Ctrl Mutualite Social A   (France)

Author keywords

Immunization; Pre exposure; Rabies

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DOSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNIZATION; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; PROGNOSIS; RABIES; SCHOOL CHILD; SEROCONVERSION;

EID: 0034212396     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00054-2     Document Type: Article

References (21)

1. Eighth report of the Expert Committee on Rabies. WHO Tech. Rep. Ser. 824:1992;24-25.
2. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 48:1999;1-21.
3. Strady A., Lang J., Lienard M., Blondeau C., Jaussaud R., Plotkin S.A. Antibody persistence following pre-exposure regimen of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. J. Infect. Dis. 177:1998;1290-1295.
4. Nicholson K.G. Modern vaccines: rabies. Lancet. 335:1990;1201-1205.
5. Mastroeni I., Vescia N., Pompa M.G., Cattaruzza M.S., Marini G.P., Fara G.M. Immune response of the elderly to rabies vaccines. Vaccine. 12:1994;518-520.
6. Kuwert E., Barsenbach C., Werner J. Early/high and late/low responders among HDCS vaccinees? Kuwert E.W.T., Koprowski H. Cell culture rabies vaccines and their protective effect in man. 1981;160-167 International Green Cross, Geneva.
7. Strady A., Lienard M., Ajjan N. Vaccination antirabique préventive en milieu professionnel exposé. Étude prospective et comparative d'immunogénicité sur 5 ans. Presse. Med. 22:1993;572-575.
8. Wiktor T.J., Plotkin S.A., Grella D.W. Human cell culture rabies vaccine. JAMA. 224:1973;1170-1771.
9. Aoki F.Y., Tyrrell D.A., Hill L.E., Turner G.S. Immunogenicity and acceptability of a human diploid cell rabies vaccine in volunteers. Lancet. i:1975;660-662.
10. Nicholson K.G., Cole P.J., Turner G.S., Harrison P. Immune responses of humans to a human diploid cell strain of rabies virus vaccine: lymphocyte transformation, production of virus-neutralizing antibody, and induction of interferon. J. Infect. Dis. 140:1979;176.
11. Dureux B., Canton P., Gerard A., Strady A., Deville J., Ajjan N. Rabies vaccine for human use cultivated on Vero cells. Lancet. ii:1986;98.
12. Klietmann W., Klietmann B., Cox J., Charbonnier C. Effectiveness and tolerance of pre- and post-exposure treatment with purified inactivated rabies vaccine prepared on Vero cell line. Vaccine. 6:1988;39-43.
13. Barth R., Diderrich G., Weinmann E. NIH test, a problematic method for testing potency of inactivated rabies vaccine. Vaccine. 6:1988;369-377.
14. Lemeshow S., Gall J.R.L. Modeling the severity of illness of ICU patients. JAMA. 272:1994;1049-1055.
15. Hanley J.A., McNeil B.J. The meaning and use of the area under a Receiver Operating Characteristic (ROC) curve. Radiology. 143:1982;29-36.
16. Barth R., Bijok U., Gruschkau H., Smerdel J., Vodopija J. Purified chicken embryo cell rabies vaccine for human use. Lancet. i:1983;700.
17. Glück R., Wegmann A., Germanier R., et al. A new, highly immunogenic duck embryo rabies vaccine. Lancet. i:1984;844-845.
18. Nicholson K.G., Farrow P.R., Bijok U., Barth R. Pre-exposure studies with purified chick embryo cell culture rabies vaccine and human diploid cell vaccine: serological and clinical response in man. Vaccine. 5:1987;208-210.
19. Arai Y., Montalban C. Comparative studies on chick embryo cell rabies vaccine and human diploid cell vaccine: pre-exposure use and purity of the vaccines. Southeast Asian J. Trop. Med. Public Health. 24:1993;747-750.
20. WHO Consultation on intradermal application of human rabies vaccines. Week. Epidemiol. Rec. 70:1995;336-337.
21. Jaiiaroensup W., Lang J., Thipkong P., et al. Safety and efficacy of purified vero cell rabies vaccine given intramuscularly and intradermally. (Results of a prospective randomized trial.). Vaccine. 16:1998;1559-1562.